Department of Biotechnology, Indian Institute of Technology Hyderabad, Kandi, Telangana State, 502285, India.
Sci Rep. 2021 Apr 14;11(1):8163. doi: 10.1038/s41598-021-87097-y.
CGG tandem repeat expansion in the 5'-untranslated region of the fragile X mental retardation-1 (FMR1) gene leads to unusual nucleic acid conformations, hence causing genetic instabilities. We show that the number of G…G (in CGG repeat) or C…C (in CCG repeat) mismatches (other than A…T, T…A, C…G and G…C canonical base pairs) dictates the secondary structural choice of the sense and antisense strands of the FMR1 gene and their corresponding transcripts in fragile X-associated tremor/ataxia syndrome (FXTAS). The circular dichroism (CD) spectra and electrophoretic mobility shift assay (EMSA) reveal that CGG DNA (sense strand of the FMR1 gene) and its transcript favor a quadruplex structure. CD, EMSA and molecular dynamics (MD) simulations also show that more than four C…C mismatches cannot be accommodated in the RNA duplex consisting of the CCG repeat (antisense transcript); instead, it favors an i-motif conformational intermediate. Such a preference for unusual secondary structures provides a convincing justification for the RNA foci formation due to the sequestration of RNA-binding proteins to the bidirectional transcripts and the repeat-associated non-AUG translation that are observed in FXTAS. The results presented here also suggest that small molecule modulators that can destabilize FMR1 CGG DNA and RNA quadruplex structures could be promising candidates for treating FXTAS.
CGG 串联重复扩展在脆性 X 智力低下-1(FMR1)基因的 5'非翻译区导致异常的核酸构象,从而导致遗传不稳定性。我们表明,G…G(在 CGG 重复中)或 C…C(在 CCG 重复中)错配(除了 A…T、T…A、C…G 和 G…C 规范碱基对)决定了 FMR1 基因的有义和反义链以及脆性 X 相关震颤/共济失调综合征(FXTAS)中它们相应的转录物的二级结构选择。圆二色性(CD)光谱和电泳迁移率变动分析(EMSA)表明,CGG DNA(FMR1 基因的有义链)及其转录物有利于四链体结构。CD、EMSA 和分子动力学(MD)模拟还表明,超过四个 C…C 错配不能容纳由 CCG 重复(反义转录物)组成的 RNA 双链体;相反,它有利于 i- motif 构象中间物。这种对异常二级结构的偏好为 RNA 焦点形成提供了令人信服的理由,因为 RNA 结合蛋白被隔离到双向转录物中,并且在 FXTAS 中观察到重复相关的非 AUG 翻译。这里呈现的结果还表明,能够使 FMR1 CGG DNA 和 RNA 四链体结构不稳定的小分子调节剂可能是治疗 FXTAS 的有前途的候选物。